Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Adults can develop late-onset loose anagen syndrome, which may often be misdiagnosed.

Finasteride effectively treats hair loss in transgender men with few side effects.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Women with PCOS tend to be less optimistic than those without it.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Women with high androgen levels may have more severe COVID-19 symptoms.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Minoxidil effectively treats female pattern hair loss.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Psychological factors play a significant role in developing alopecia areata.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

PCOS has many symptoms, with high androgen levels being the most common.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Facial hair is crucial for transgender men's gender identity and transition.